2-3% royalty. But the sales value of raw TPM is massive and the Mastitis formula contains a significant amount of TPM. . TPM costs POH next to nothing to manufacture so this is very profitable deal if it gets up. POHs in house trials suggest another winnner. Balls with the USDA.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(10.0%) |
Mkt cap ! $14.28M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $1.275K | 283.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 10548899 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 23942354 | 24 |
View Market Depth
| Last trade - 15.57pm 15/07/2025 (20 minute delay) ? |
| AVE (ASX) Chart |